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Abstract
Activation of dendritic cells by different pathogens induces the secretion of proinflammatory mediators resulting in
local inflammation. Importantly, innate immunity must be properly controlled, as its continuous activation leads to the
development of chronic inflammatory diseases such as psoriasis. Lipopolysaccharide (LPS) or peptidoglycan (PGN)
induced tolerance, a phenomenon of transient unresponsiveness of cells to repeated or prolonged stimulation,
proved valuable model for the study of chronic inflammation. Thus, the aim of this study was the identification of the
transcriptional diversity of primary human immature dendritic cells (iDCs) upon PGN induced tolerance. Using SAGE-
Seq approach, a tag-based transcriptome sequencing method, we investigated gene expression changes of primary
human iDCs upon stimulation or restimulation with Staphylococcus aureus derived PGN, a widely used TLR2 ligand.
Based on the expression pattern of the altered genes, we identified non-tolerizeable and tolerizeable genes. Gene
Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (Kegg) analysis showed marked enrichment of
immune-, cell cycle- and apoptosis related genes. In parallel to the marked induction of proinflammatory mediators,
negative feedback regulators of innate immunity, such as TNFAIP3, TNFAIP8, Tyro3 and Mer are markedly
downregulated in tolerant cells. We also demonstrate, that the expression pattern of TNFAIP3 and TNFAIP8 is
altered in both lesional, and non-lesional skin of psoriatic patients. Finally, we show that pretreatment of immature
dendritic cells with anti-TNF-α inhibits the expression of IL-6 and CCL1 in tolerant iDCs and partially releases the
suppression of TNFAIP8. Our findings suggest that after PGN stimulation/restimulation the host cell utilizes different
mechanisms in order to maintain critical balance between inflammation and tolerance. Importantly, the transcriptome
sequencing of stimulated/restimulated iDCs identified numerous genes with altered expression to date not associated
with role in chronic inflammation, underlying the relevance of our in vitro model for further characterization of IFN-
primed iDCs.
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Introduction
Plants and animals are constitutively exposed to various
pathogens present in the environment including commensal
and pathogenic microorganisms. Despite the constant
presence of pathogens, infections still develop infrequently,
partly because all multicellular organisms have evolved
defense mechanisms to combat against harmful microbes [1].
As the inflammation causes dramatic changes in tissue
physiology, inflammatory responses must be strictly regulated
otherwise uncontrolled inflammation leads to serious pathologic
conditions (eg. septic shock, autoimmunity, atherosclerosis) [2].
Numerous regulatory mechanisms, such as the production of
anti-inflammatory cytokines or the induction of negative
feedback regulators of the TLRs, i.e. members of the SOCS
family [3,4] or TNFAIP3 [5] have been described that are
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preventing the host from the harmful side effects of
uncontrolled inflammation.
These molecules also have pivotal role in the long-lasting
hyporesponsiveness of the cells and organisms to prolonged/
repeated LPS stimulation, a phenomenon called LPS tolerance
[6,7]. For a long time LPS tolerance was thought to be a
consequence of receptor desensitization [8,9] and it has only
recently been demonstrated that transient silencing of pro-
inflammatory genes at chromatin level has essential role in the
maintenance of LPS tolerance [10]. Foster et al. treated
primary mouse macrophages with LPS once or repeatedly and
monitored the relative gene expression of inflammatory genes.
They found that cytokines such as IL-6 or IL-1β were
upregulated after the first LPS stimulation, however they were
not re-induced or induced to a much lesser degree after the
second LPS challenge, a phenotype defined as tolerizeable. In
contrary to cytokines, the relative gene expression of
antimicrobial peptides (i.e. cathelicidin-related antimicrobial
peptide) proved to be inducible after the second LPS treatment,
a phenotype defined as non-tolerizeable. More accurate
analysis of these phenotypes demonstrated that covalent
histone modifications play important role in the maintenance of
LPS tolerance. Even though promoters of both tolerizeable and
non-tolerizeable genes were inducibly acetylated, a hallmark of
transcriptional activity, in naïve macrophages, only the non-
tolerizeable promoters were re-acetylated after LPS treatment
in tolerant cells [10]. These data present a novel mechanism
for the regulation of LPS tolerance, yet, little is known about
transcriptional diversity of PGN tolerance.
In order to get a global view on the gene expression changes
of primary human immature dendritic cells (iDCs) upon
stimulation or restimulation with Staphylococcus aureus
derived PGN, a widely used TLR2 ligand, we have performed
SAGE-Seq analysis [11]. Based on the expression pattern of
the altered genes, we identified non-tolerizeable and
tolerizeable genes; a finding resembling that of LPS tolerance
[10]. GO gene set enrichment and Kegg pathway analysis
showed marked enrichment of immune-, cell cycle- and
apoptosis related genes. We also demonstrate, that the
expression pattern of TNFAIP3 and TNFAIP8, to date not
associated with psoriasis, is altered in both lesional, and non-
lesional skin of psoriatic patients. Finally, we show that
pretreatment of immature dendritic cells with anti-TNF-α inhibits
the expression of IL-6 and CCL1 in tolerant iDCs and partially
derepresses TNFAIP8 expression. Importantly, based on the
results obtained using the model of PGN induced tolerance and
subsequent transcriptome analysis, we were able to identify
genes with altered expression in inflammatory diseases such
as psoriasis (this study) and TNBS-induced rat model of colitis
(unpublished), which underlies the relevance of the in vitro
model for further characterization of IFN-primed iDCs.
Results and Discussion
PGN stimulation and restimulation differentially alters
the global gene expression profile of primary human
iDCs
Based on the LPS tolerance model [10] we have first
established a model for acute and chronic PGN stimulation, in
which we treated primary human immature dendritic cells
(iDCs) once or repeatedly (stimulation/restimulation) with
Staphylococcus aureus derived peptidoglycan (PGN). For the
clarity, throughout the manuscript we will use terms induced or
N+PGN and tolerant or T+PGN for PGN stimulated or
restimulated iDCs, respectively. Next, in order to get a global
view on the gene expression pattern of induced or tolerant
primary human iDCs (Figure 1A), SAGE-Seq experiments were
performed.
In our experiments we are purifying monocytes from buffy-
coats of healthy blood donors and are subsequently
differentiating them into immature dendritic cells. Since there
are a limited number of monocytes in the buffy-coat, we only
have a limited number of dendritic cells at the end of
differentiation process. Moreover, dendritic cells are non-
dividing cells: these features restrict the amount of purified total
RNA per sample. Taking all these facts together we opted for
pooling RNA samples, isolated from three independent
experiments, in equimolar concentration and subsequently
sequenced the pooled RNA: this experimental setup ensured
the biological heterogeneity of the samples. Even though this
experimental design, which is pooling of input RNA, does not
permit the estimation of expression variation within treatments,
it does facilitate the determination of the fold-change
expression changes between treatments. By applying a
Bayesian statistical method for testing significance, which is not
based on sample variance, but rather on the probability density
functions defined by the number of the observed sequenced
tags [12], we have altogether identified 5411 genes with
significantly altered expression pattern after PGN stimulation/
restimulation (Figure 1B). Between naïve (N) and induced (N
+PGN) iDCs 2840 genes were found which had significant
changes in their expression pattern. Importantly, 804 out of
2840 genes were uniquely characteristic for this category. PGN
restimulation altered the expression pattern of 3647 genes
(comparison of naïve (N) and tolerant (T+PGN) iDCs)), with
1016 uniquely altered genes. Finally, the gene expression of
566 out of 2346 genes uniquely changed between induced (N
+PGN) and tolerant (T+PGN) iDCs. We hypothesized that
genes differentially altered in this latter comparison may
represent the differences between acute and chronic
Staphylococcal infection.
To characterize the potential relevance of the alterations
resulted by PGN stimulation/restimulation, pathway and gene
set enrichment analysis was carried out using Kegg (Kyoto
Encyclopedia of Genes and Genomes) database (Figure 1D
and Table S2) and the Biological Processes (BiolProc) domain
of Gene Ontology Project (Figure 1C and Table S1). Although
Kegg allows for a more accurate analysis by providing
consistent and standardized annotations by linking individual
genes to components of the Kegg biochemical pathways [13]
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we used both pathway analysis tools to reduce the possibility of
false results. Both PGN stimulation and restimulation induced
massive enrichment of both BiolProc GO terms and Kegg
pathways, particularly from the functional groups immune
response, apoptosis and cell cycle (Figure 1C, D and Table S1,
S2). These results are not surprising, taking into account the
fact that iDCs are known to rapidly respond to immune
challenge [14], in this case PGN. However, when comparing
the gene expression patterns of induced vs. tolerant iDCs, both
pathway analysis tools highlighted significant downregulation of
a number of, primarily, genes from the immune response
functional group (Figure 1C, D and Table S1, S2). These
results suggest the induction of tolerogenic mechanism after
persistent PGN stimulation similarly to that observed in a model
of LPS tolerance [10].
Based on the results of the pathway analysis and taking into
account the specific feature of the SAGE-Seq technology,
namely that NlaIII - the enzyme used to fragment mRNA - has
recognition site of approximately every 200-300 nucleotides in
the human genome, we investigated the expression pattern of
individual sequence tags. This latter represents the short
subsequence of an mRNA and is used to identify gene
transcripts in SAGE-Seq experiments. Foster et al. have
recently used an LPS induced model of tolerance in murine
macrophages and have shown that TLR-induced genes fall into
non-tolerizeable and tolerizeable categories [10]. We were
particularly interested if these categories can be identified in
our model of PGN induced tolerance and have thus specifically
screened sequence tag patterns for the four categories shown
on Figure 1E. Indeed, 427 sequence tags fall in one out of four
monitored categories (Figure 1E), a finding resembling that of
LPS tolerance [10]. In the first two categories, PGN stimulation
leads to the upregulation of 255 out of 427 tested tags, in
contrast, two other categories are comprised of those 172 tags
that are downregulated in induced iDCs. Expression pattern of
the tested tags (206 up- and 221 downregulated tags) in
tolerant iDCs further subdivides these categories. Here we
describe the four monitored categories in more detail. The first
category is comprised of those 74 tags out of 427 tested where
the upregulation in induced iDCs as compared to naïve cells is
observed, and these tags are even further upregulated in
tolerant iDCs (Figure 1E, upper panel). Notably, genes of the
Figure 1.  Identification of differentially expressed genes upon PGN stimulation and re-stimulation of immature dendritic
cells.  (A) Dendritic cell stimulation and sample collection. Immature dendritic cells were left unstimulated (naïve iDCs; N),
stimulated with PGN (induced iDCs; N+PGN) or re-stimulated with PGN (tolerant iDCs; T+PGN) mimicking acute or chronic
infection, respectively. Total RNA and cell culture supernatants were harvested at 27 and 48 hours post first PGN induction. (B)
Venn diagram summarizing the distribution of the 5411 differentially expressed genes (p>0.95, calculated by the Bayesian approach
described by Lash et al [12].) identified by SAGE-Seq; each cycle represents the pairwise comparison indicated. (C) Gene Ontology
and (D) Kegg pathways enriched for genes differentially expressed in the given pairwise comparison. The numbers denotes the
cumulative number of genes detected for a particular GO or Kegg term. (E) Based on the classification of genes as non-tolerizeable
(genes inducible in tolerant cells) and tolerizeable (genes not inducible in tolerant cells) by Foster et al. [10] four such gene
expression patters were identified upon SAGE-Seq analysis comparing naïve vs. induced or tolerant iDCs.
doi: 10.1371/journal.pone.0073435.g001
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immune response GO term and Kegg pathways belonging to
eg. cytokine and chemokine signaling biological processes, fell
into this category. In contrast, 181 tags were significantly
downregulated in tolerant iDCs, as compared to their induction
in induced iDCs: these tags belong to the second category
where an enrichment of genes from the Toll-like receptor
signaling pathway is observed (Figure 1E, second panel).
These data are in complete agreement with those observed in
a model of LPS tolerance, where these two categories are
designated as class non-tolerizeable and tolerizeable,
respectively [10]. 132 tags are classified into the third category,
which is comprised of genes showing down-regulation in
induced and upregulation in tolerant iDCs, such as those of the
antigen processing and presentation pathway (Figure 1E, third
panel). Finally, the remaining 40 tags show further
downregulation in tolerant iDCs, as compared to that observed
in induced cells, eg. apoptosis and cell cycle related genes
(Figure 1E, bottom panel).
Together with results collected using the model of LPS
tolerance, our data on PGN tolerance further strengthens the
view that even attenuated signaling through pattern recognition
receptors, such as TLRs, is sufficient for the induction of a
number of genes [10]. In the course of our study, we were
primarily interested to identify those genes that show
significantly altered gene expression pattern when comparing
induced and tolerant iDCs, as we hypothesize that this
approach may facilitate the identification of genes responsible
for the development and maintenance of chronic inflammation.
SAGE-Seq experiments indeed indicate that our in vitro
experimental model provides valuable tool for identifying
differences at the gene expression level between acute and
chronic infection.
Stimulation and restimulation of iDCs with PGN
differentially alters the expression of immune related
genes
Since SAGE-Seq approach does not allow the determination
of exact relative gene expression values, just the direction of
altered expression (i.e. up- or downregulation) we decided to
more accurately examine the expression levels of selected
molecules. For this, and based on SAGE-Seq and subsequent
pathway analysis and enrichment studies we have chosen
members of the immune response, apoptosis, and cell cycle
functional groups in order to more accurately analyze their
relative gene expression and secreted protein level by QRT-
PCR and ELISA, respectively.
PGN stimulation resulted in significant relative gene
expression upregulation of the majority of investigated immune
effector molecules such as CXCL8, CCL1, CXCL10, IL-6, IL-10
and IL-17A (Figure 2A–F) compared with naïve cells.
Furthermore, all except CXCL-10 showed significant further
relative gene expression upregulation in tolerant iDCs; these
five are classified as non-tolerizeable genes. Surprisingly,
although IL-10 has primarily anti-inflammatory role, we
detected its significantly increased expression in both induced
and tolerant iDCs (Figure 2E), suggesting that both pro- and
anti-inflammatory mechanisms are simultaneously induced
upon PGN stimuli. Importantly, the expression of IFN-γ
inducible CXCL10 in tolerant iDCs was completely abolished,
thus it belongs to class tolerizeable genes (Figure 2C).
We also aimed to determine the impact of PGN stimulation/
restimulation on the relative gene expression pattern of
selected cytokine receptors. Our data demonstrate that the
expression of CCR8 (receptor for CCL1; data not shown),
gp130 (receptor for IL-6; Figure 2G), IL-10RA (receptor for
IL-10; Figure 2H) and that of IL-17RA (receptor for IL-17A;
Figure 2I) all show significant dowregulation in both induced
and tolerant iDCs. This opposite expression pattern of
cytokines and their respective receptors suggest a paracrine
role for the induced cytokines, which is in agreement with the
primary function of iDCs playing role in antigen uptake and the
recruitment of other effector cells to the site of the infection
[15].
SAGE-Seq experiments identified numerous members of the
TNF-α related genes being differentially expressed between
induced and tolerant iDCs (data not shown). Since TNF-α is,
together with IL-1α and IL-6, an acute-phase molecule having
pivotal role in the early immune response against invading
pathogens, we decided to determine the exact expression
pattern of selected members of the family. Our data
demonstrates that the robust expression of TNF-α in induced
iDCs is abolished in tolerant cells (Figure 3A, F) supporting
earlier findings showing its rapid inducibility and fading [16].
The expression pattern of TNFAIP3 follows that of TNF-α,
being abolished in tolerant cells, thus both belonging to the
class tolerizeable genes. Since anti-TNF-α pretreatment had no
significant effect on the expression of these two molecules
(Figure 4A, B), we suggest their expression pattern is indeed a
direct consequence of PGN stimulation/restimulation and not a
secondary effect of de novo TNF-α secretion.
Opposed to TNF-α and TNFAIP3, the relative gene
expression of TNFAIP6 (TNF-α-stimulated gene 6; also known
as TSG6) as well as TNFSF15 (also known as TL1A) was
significantly induced in tolerant iDCs (Figure 3C, D). Since both
molecules are directly inducible by TNF-α stimulation we
sought to determine if their elevated expression in tolerant
iDCs is a consequence of TNF-α secretion evoked by PGN
induction. Surprisingly, by using anti-TNF-α pretreatment, we
were unable to abolish the elevated expression of TNFAIP6
and TNFSF15 in tolerant iDCs (data not shown). As both
molecules play important roles in the pathogenesis of
autoimmune diseases [17], these results offer an interesting
aspect for the partial unsuccessfulness of anti-TNF-α therapies:
we suggest that TNF-α is not the only factor triggering the
expression of genes classified as TNF-α inducible.
We have also determined that the expression of the negative
regulator of innate immunity TNFAIP8 (also known as TIPE2) is
significantly downregulated in induced iDCs and further
downregulated in tolerant cells (Figure 3E). Recent reports
demonstrated that TNFAIP8 is predominantly expressed in
immune cells where it negatively regulates T cell receptor
(TCR) and TLR signaling [18–20]. The absence of TNFAIP8
expression results in hyper-responsiveness to TCR and TLR
activation and enhanced pro-inflammatory cytokine secretion.
This is in line with our findings showing that PGN restimulation
results in significant gene expression downregulation of
Transcriptome Profiling of Dendritic Cells
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Figure 2.  Different expression pattern of pro-inflammatory
mediators and receptors in induced and tolerant iDCs at
27h.  The relative gene expression of pro-inflammatory
effectors such as CXCL8 (A), CCL1 (B), CXCL10 (C), IL-6 (D),
IL-10 (E) and IL-17A (F) shows significant upregulation in
induced (N+PGN) as compared to the naïve (N) iDCs. The
expression of CXCL8 (A), CCL1 (B), IL-6 (D) and IL-17A (F)
shows further upregulation in tolerant iDCs (T+PGN) as
compared not only to the naive but to the induced iDCs as well.
In contrast, the expression of CXCL10 (C) in tolerant iDCs is
significantly downregulated when compared both to naïve and
induced iDCs. In contrast to the effector molecules, receptors
involved in inflammation such as gp130 (G), IL-10RA (H) and
IL-17RA (I), were significantly down regulated in both induced
and tolerant iDCs as compared to naïve cells. The ratio of each
mRNA relative to the 18S rRNA was calculated using the 2-ΔΔCT
method. Data are representative of 3 or more independent
experiments and are presented as interquartile range (box)
with median (horizontal black bar) and minimum and maximum
values. The significance of differences between sets of data
was determined by Student’s paired t-test using SPSS
Statistics; *p<0.05.
doi: 10.1371/journal.pone.0073435.g002
Figure 3.  TNF-α and TNF-α regulated genes show distinct
expression pattern in induced and tolerant iDCs at
27h.  The relative gene expression of pro-inflammatory
effectors such as TNF-α (A), TNFAIP3 (B), TNFAIP6 (C) and
TNFSF15 (D) shows significant upregulation in induced iDCs
as compared to naive cells. The expression of TNFAIP6 and
TNFSF15 shows further upregulation in tolerant iDCs as
compared to the induced cells (C, D), in contrast, the
expression of TNF-α (A) and TNFAIP3 (B) in tolerant iDCs are
significantly downregulated when compared to induced iDCs.
TNFAIP8 (E) is significantly downregulated in both induced and
tolerant iDCs. (F) Secreted TNF-α protein level was determined
from cell culture supernatants by ELISA at 48h. In accordance
with relative gene expression results, both stimulation and
restimulation of iDCs with PGN induces significant TNF-α
protein secretion. The ratio of each mRNA relative to the 18S
rRNA was calculated using the 2-ΔΔCT method. Data are
representative of 3 or more independent experiments and are
presented as interquartile range (box) with median (horizontal
black bar) and minimum and maximum values. The
significance of differences between sets of data was
determined by Student’s paired t-test using SPSS Statistics;
*p<0.05.
doi: 10.1371/journal.pone.0073435.g003
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TNFAIP8 and, in parallel, upregulation of numerous cytokines
and chemokines eg. CXCL8, CCL1, IL-6, IL-17A, TNF-α etc.
Finally, our results, showing the release of the TNFAIP8
inhibition and, in contrast, inhibition of IL-6 and CCL1
expression in tolerant iDCs by anti-TNF-α pretreatment (Figure
4C–F) suggests that, apart of PGN, de novo synthesized TNF-
α indeed regulates the expression of TNFAIP8, IL-6 and CCL1.
Similarly to TNFAIP8, TAM family of receptor tyrosine
kinases, consisting of Tyro3, Axl and Mer, play central role in
the intrinsic inhibition of the inflammatory response to
pathogens [21]. Rothlin et al. have reported that TAM activation
of murine DCs inhibits the secretion of effector molecules, such
Figure 4.  Targeting TNF-α with infliximab decreases the
expression of IL-6 and CCL1 in tolerant iDCs at
27h.  Soluble chimeric monoclonal anti-TNF-α antibody
(infliximab) was added to the culture supernatant in a
therapeutic concentration (white bars) and the effects on gene
and protein expression were monitored by QRT-PCR (A–E)
and ELISA (F). Samples without infliximab treatment (gray
bars) were used as controls. While infliximab pre-treatment has
no effect on the expression of TNF-α (A), TNFAIP3 (B),
TNFAIP8 (C), IL-6 (D) and CCL1 (E, F) in naïve and induced
iDCs, it partially releases the inhibition of TNFAIP8 (C) and
significantly dowregulates the expression of IL-6 (D) and CCL-1
(E, F) in tolerant iDCs. The ratio of each mRNA relative to the
18S rRNA was calculated using the 2-ΔΔCT method. Data are
representative of 3 or more independent experiments and are
presented as interquartile range (box) with median (horizontal
black bar) and minimum and maximum values. The
significance of differences between sets of data was
determined by Student’s paired t-test using SPSS Statistics;
*p<0.05.
doi: 10.1371/journal.pone.0073435.g004
as cytokines and chemokines [22]. Notably, in our experimental
model, the expression of all three molecules is significantly
downregulated in both induced and torelant iDCs (Figure 5A–
C); in addition, the expression of Tyro3 and Mer is further
downregulated in tolerant iDCs (Figure 5A and C). This is in
line with the observed elevated level of cytokine and
chemokine gene expression; moreover these data are in
accordance with the recently reported marked downregulation
of TAM receptor tyrosine kinases in psoriatic epidermis [23].
In order to determine if the identified gene expression
patterns are specific to the given sampling time point, that is at
27h post first PGN stimulation, we have analyzed the
expression pattern of seven genes at 48h post first PGN
stimulation (Figure S1, S2). The results show, that all but
TNFAIP3 retained their expression pattern detected at 27h post
first PGN stimulation, although with a slightly altered kinetics.
PGN stimulation downregulates the expression of cell
cycle- and apoptosis-related genes
The strict regulation of cell division cycle has fundamental
role in the maintenance of tissue homeostasis. As cyclins and
cyclin-dependent kinases regulate the transition of different
phases of cell cycle and, based on pathway analysis of SAGE-
Seq data, numerous members seem to be suppressed in both
induced and tolerant iDCs (Figure 1E) we examined the impact
Figure 5.  The expression of TAM receptor family in
induced and tolerant iDCs at 27h.  The relative gene
expression levels of Tyro3 (A), Axl (B) and Mer (C) were
determined by QRT-PCR. All three genes show significantly
dowregulated expression in induced iDCs when compared to
naive cells (N+PGN samples). In addition, the expression of
Tyro3 and Mer is further downregulated in tolerant iDCs as
compared to induced iDCs. The ratio of each mRNA relative to
the 18S rRNA was calculated using the 2-ΔΔCT method. Data are
representative of 3 or more independent experiments and are
presented as interquartile range (box) with median (horizontal
black bar) and minimum and maximum values. The
significance of differences between sets of data was
determined by Student’s paired t-test using SPSS Statistics;
*p<0.05.
doi: 10.1371/journal.pone.0073435.g005
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of PGN stimulation on the gene expression of cyclin B2
(CycB2; Figure 6A) which is involved in G2-M transition and
cyclin D1 (CycD1; Figure 6B) which has central role in G1-S
transition [24]. QRT-PCR approach indeed corroborated
SAGE-Seq data, demonstrating that PGN stimulation/
restimulation resulted in significant relative gene expression
downregulation of both CycB2 and CycD1. These findings,
together with the fact that DCs are non-dividing cells, suggest
that cross-linking of immune receptor with its respective ligand,
in this case TLR2-PGN, induces maturation process which is
characterized by functional differentiation of the antigen
presenting cells without numeral expansion.
The induction of apoptotic processes has important role in
the maintenance of the transient nature of the immune
response [25,26]. Pathway analysis, showing the enrichment of
apoptosis related genes in our model (Figure 1C–E), prompted
us to investigate the impact of PGN stimulation on the relative
gene expression of three molecules involved in the regulation
of cell fate and apoptosis. We have determined, that
caspase-8, Fas-associated protein with death domain (FADD)
and TGF-β are all significantly downregulated upon PGN
stimulation (Figure 6C–E). While we could not detect any
difference in the suppression of caspase-8 and FADD gene
expression between induced and tolerant iDCs, the
suppression of TGF-β in tolerant iDCs is significantly lower.
Since the downregulation of proapoptotic genes does not
necessarily imply resistance to apoptosis, we sought to define
the apoptosis of induced and tolerant iDCs. We monitored the
amount of phosphatidylserine expressed on cell membrane in
the early phase of apoptosis, and found reduced expression in
both induced and tolerant iDCs as compared to naïve cells
(Figure 6F). The role of programmed cell death is not limited to
the maintenance of tissue homeostasis, it has pivotal role in
preventing the organism against the development of
autoimmune diseases [27]. Hence, by dowregulating this
pathway tolerant iDCs may play a role in the development of
autoimmune diseases. In addition, our data show strong
correlations with earlier findings showing that the down
regulation of FADD enhances the relative gene expression of
IL-1β, IL-6, IL-10 and TNF-α in mouse epidermis [5].
These data suggest that acute and persistent Staphylococcal
infection inhibits cell division cycle by downregulating the
expression of cyclins, moreover, the reduced expression level
of proapoptotic genes suggests the induction of prosurvival
mechanisms which may, in turn, lead to prolonged antigen
presentation and the elimination of invading pathogens.
The expression pattern of TNF-α related genes from
psoriatic skin shows similar expression pattern with
that observed in our in vitro model
We have determined, that pro- and anti-inflammatory
molecules maintain critical balance during acute and chronic
PGN stimuli to successfully eliminate invading pathogens and
to prevent the host against the harmful side effects of
uncontrolled inflammation. Although the pathogenesis of
psoriasis has not been fully understood yet, the immunological
basis of this disease has been well demonstrated [28]. It is well
known that the enhanced level of proinflammatory mediator
TNF-α has pivotal role in the pathogenesis of psoriasis [29]. In
addition, a previous report demonstrated strong nuclear
immunopositivity for TNFSF15 in psoriatic skin samples, in
Figure 6.  The expression of cell cycle and apoptosis
regulators in induced and tolerant iDCs at 27h.  Based on
the SAGE-Seq data, we have chosen 2 cell cycle regulators,
cyclin B2 (A) and cyclin D1 (B), and three apoptosis regulators,
caspase-8 (C), FADD (D) and TGF-β (E) for the validation by
QRT-PCR. All of the selected genes show significantly
dowregulated expression in both induced and tolerant iDCs
when compared to naive cells. In addition, while still
downregulated relative to naive cells, the expression of TGF-β
in tolerant iDCs is significantly upregulated as compared to
induced iDCs (E). (F) Induced and tolerant iDCs exhibit
decreased apoptosis as determined by fluorescence intensity
measurements of phosphatidylserine expressed on cell
membrane, measured with Annexin V-Alexa Fluor 488 binding.
The ratio of each mRNA relative to the 18S rRNA was
calculated using the 2-ΔΔCT method. Data are representative of 3
or more independent experiments and are presented as
interquartile range (box) with median (horizontal black bar) and
minimum and maximum values except for the
phosphatidylserine expression intensity (F). The significance of
differences between sets of data was determined by Student’s
paired t-test using SPSS Statistics; *p<0.05.
doi: 10.1371/journal.pone.0073435.g006
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contrast, TNFSF15 was absent in healthy skin samples [17].
However, little is known about the expression pattern of other
TNF-α related genes in the course of this autoimmune disease.
In order to determine the relative gene expression pattern of
TNFAIP3, TNFAIP6 and TNFAIP8 in plaque-type psoriasis we
have performed QRT-PCR experiments on psoriatic non-
lesional and lesional dermal and epidermal samples. As
controls, skin biopsy samples form healthy individuals were
used.
First, we examined the relative gene expression pattern of
TNF-α. In agreement with earlier studies we found that the
relative gene expression level of TNF-α is upregulated in
psoriatic non-lesional epidermal and dermal samples compared
with healthy samples (Figure 7A). Furthermore, in lesional
samples a more robust upregulation was detected as
compared to non-lesional counterparts. As these data, together
with those showing elevated expression of CXCL-8 in lesional
epidermis [30], corroborate earlier findings [31] we used these
samples for further experiments.
In accordance with PGN restimulated iDCs (Figure 3C) the
relative gene expression of TNFAIP6 is significantly
upregulated in psoriatic non-lesional and lesional epidermal
samples compared to healthy skin (Figure 7C; gray bars). In
non-lesional dermal samples significant gene expression
downregulation was detected as compared to healthy skin, in
contrast, we detected robust gene expression upregulation in
lesional samples (Figure 7C; open bars). In contrary to the pro-
inflammatory mediators, the anti-inflammatory effector
molecules, TNFAIP3 and TNFAIP8 (Figure 7B and D,
respectively) were both downregulated in psoriatic non-lesional
and lesional epidermal and dermal samples as compared to
healthy controls. Again, these results show strong correlations
with those obtained in PGN restimulated iDCs (Figure 3B and
E, respectively). Of note, TNFAIP3 deficient mice die early after
the birth due to serious multi-organ inflammation [32] and the
targeting of TNFAIP3 in different cell types was shown to be
associated with chronic inflammation and autoimmunity
[33–35]. Furthermore the expression of TNFAIP3 in peripheral
blood mononuclear cells of psoriatic patients negatively
correlates with disease severity [36], and TNFAIP3 gene has
been identified as a susceptibility locus for several autoimmune
disorders, including psoriasis [37]. TNFAIP8 is also an
essential negative regulator of inflammation [18] and is also
involved in the protection against apoptosis [38]. To the best of
our knowledge this is the first report demonstrating the
significant downregulation of TNFAIP3 and TNFAIP8 in
psoriatic dermis and epidermis which may explain the
enhanced cytokine production and the decreased sensitivity to
pro-apoptotic processes characteristic for psoriasis.
Collectively, we have successfully used the results obtained
on tolerant iDCs to identify genes with altered expression
pattern in psoriatic skin. Our results suggest that beside the
enhanced level of TNF-α, the elevated expression of TNFAIP6
also has important role in the maintenance of chronic
inflammation which is characteristic for psoriasis. Furthermore,
the downregulation of negative regulators TNFAIP3 and
TNFAIP8 (this study), as well as members of the TAM receptor
family [30] in psoriasis, suggest that negative feedback
regulators of inflammation are disturbed in psoriasis which
may, partly, explain chronic inflammation.
Figure 7.  The expression level of selected genes in
psoriasis.  Shave biopsy specimens were taken from healthy
individuals (controls without psoriasis; n=3) and from psoriatic
patients (n=3): both lesional and non-lesional samples were
taken from this latter group. RNAs were isolated from
epidermis (grey box) and dermis (white box), the gene
expression levels were determined by QRT-PCR and
represented relative to healthy skin. We have detected
significant induction in the expression of TNF-α (A) in both non-
lesional and lesional skin of psoriatic patients. Similar
expression pattern was observed in case of TNFAIP6 (C),
although its expression in non-lesional epidermis shows
significant downregulation. In contrast, TNFAIP3 (B) and
TNFAIP8 (D) show significant downregulation. Data are
representative of 3 or more individuals; *p<0.05.
doi: 10.1371/journal.pone.0073435.g007
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Targeting TNF-α with infliximab derepresses TNFAIP8
and decreases the expression of IL-6 and CCL1 in
tolerant iDCs
Based on the more specific understanding of the
pathogenesis of skin inflammatory conditions at a molecular
level, the inhibition of pro-inflammatory mediators with
antibodies or soluble receptors became the mainstream
therapy to treat dermatologic diseases, such as psoriasis or
atopic dermatitis [39,40]. As TNF-α plays central role in the
pathogenesis of psoriasis it represents an active target for
biological therapies, hence, numerous TNF-α blocking agents
are used to treat psoriasis. Even though TNF-α is thought to be
an instigator of inflammation, little is known about downstream
molecular effect of TNF-α blocking. Our results, demonstrating
that the expression pattern of tolerant iDCs can be used for
identification of genes with altered expression in chronic
inflammatory conditions such as psoriasis (see above) or colitis
(unpublished) prompted us to test the impact of TNF-α
deprivation at cellular level. The application of infliximab did not
altered TNF-α and TNFAIP3 gene expression (Figure 4A, B)
suggesting that their expression in our model is TNF-α
independent. Infliximab did, however, markedly reduced the
relative gene expression of IL-6 in tolerant iDCs (Figure 4D).
This is in good agreement with earlier findings showing that
infliximab significantly reduced the relative gene expression of
acute-phase proteins such as IL-1β and IL-6 [41]. Moreover,
we observed significant derepression of TNFAIP8 gene
expression in tolerant cells (Figure 4C) suggesting that, at least
partially, TNF-α directly represses its expression.
CCL1 inflammatory chemokine plays a central role during the
recruitment of activated T cells and CCR8+ DCs to the site of
skin inflammation [42]. In order to determine if the significantly
induced CCL1 expression in tolerant DCs (Figure 2B) is TNF-α
dependent we again used infliximab pretreatment. Indeed,
infliximab abolished CCL1 gene expression and protein
secretion (Figure 4E, F, respectively) in tolerant iDCs indicating
that TNF-α plays a major role in PGN-induced CCL1
expression. This is in agreement with the finding showing that
TNF-α induces the expression of CCL1 in macrophages [43].
Taking into account recent reports demonstrating elevated
CCL1 expression is atopic dermatitis [42,44] our results may
provide an additional explanation for the successful application
of anti-TNF-α therapy in atopic dermatitis [40]: by targeting
TNF-α the downstream expression of CCL1 is decreased
attenuating thereby the initiation and amplification of atopic skin
inflammation.
Conclusions
This study utilized transcriptomic data obtained from the
model of PGN tolerance in primary human immature dendritic
cells (iDCs) in order to obtain a list of putative candidate genes
differentially expressed upon acute and chronic infection.
Based on their expression pattern, 427 sequence tags
clustered in one of four monitored categories with remarkable
expression differences observed when comparing induced vs.
tolerant cells. Our findings suggest that after PGN stimulation/
restimulation the host cell utilizes different mechanisms in order
to maintain critical balance between inflammation and
tolerance leading to the elimination of impending pathogens
and protecting the host against harmful side effects resulting
from uncontrolled inflammation. Importantly, a selection of
genes with differential expression in induced and/or tolerant
iDCs shows similar expression pattern in chronic inflammatory
conditions, such as psoriasis (this study and [30]) or TNBS-
induced colitis in rats (unpublished) underlying the relevance of
the in vitro model for further characterization of IFN-primed
iDCs.
Materials and Methods
Monocyte isolation and dendritic cell differentiation
Buffy coats of healthy blood donors were obtained from the
Hungarian National Blood Transfusion Service, Szeged,
Hungary. Importantly, to limit the person-to-person variability as
much possible, we used buffy-coats of Rh+ type A group blood
donors (A+) in all our experiments. From these preparations
peripheral blood mononuclear cells (PBMCs) were separated
by Ficoll Paque Plus (GE Healthcare) density gradient
centrifugation as described previously [45]. In brief, monocytes
were isolated by adherence on tissue culture plastic plates.
Immature dendritic cells (iDCs) were obtained by culturing
monocytes for five days in RPMI-1640 medium (Gibco)
supplemented with 10% heat-inactivated FBS (Gibco), 1%
penicillin/streptomycin solution (Gibco), 1000 units/ml
recombinant human granulocyte-macrophage colony
stimulating factor (GM-CSF, Sigma) and 1000 unit/ml
recombinant human interferon-α (IFN-α, Sigma). Cells were
cultured at 37oC in an atmosphere of 5% (v/v) CO2 in air.
iDC stimulation and sample collection
iDCs were treated with 10μg/ml Staphylococcus aureus (S.
aureus) derived peptidoglycan (PGN, Sigma) according to the
model described in Figure 1. Briefly, iDCs were left untreated
(naïve, N), stimulated (induced; N+PGN) or restimulated
(tolerant; T+PGN) with 10µg/ml PGN, in order to mimic acute
or chronic infection. In some experiments, soluble chimeric
monoclonal anti-TNF-α antibody (infliximab, Schering-Plough)
was added to primary monocytes in parallel with GM-CSF and
IFN-α. Infliximab has a long half-life of approximately 10 days,
which ensured the neutralization of all secreted TNF-α protein
during iDC generation. Moreover, freshly prepared infliximab
was added to the culture supernatants along with PGN
stimulations in order to neutralize de novo synthesized and
secreted TNF-α. Total RNA and cell culture supernatants were
collected at 27 and 48 hours post first PGN treatment, that is 3
and 24 hours post second PGN treatment.
Quantitative reverse transcriptase polymerase chain
reaction (QRT-PCR)
Total RNA was extracted from iDCs using RNeasy Plus Mini
Kits (Qiagen) according to the manufacturer’s instructions. The
quality and quantity of extracted RNA was determined using
NanoDrop (Thermo Scientific), Qubit (Life Technologies) and
Bioanalyzer (Agilent) measurements. cDNA was synthesized
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from at least 100ng of total RNA by using the High Capacity
RNA to cDNA Kit (Life Technologies) according to the
manufacturer’s instructions. SybrGreen and TaqMan
technology based real-time quantitative PCR was used to
quantify the relative abundance of the selected mRNAs. For
this, specific exon spanning gene expression assays were
used; TaqMan assay IDs and primer sets are listed in Tables 1
and 2, respectively. As controls, we used reaction mixtures
without cDNA. All of the measurements were performed in
duplicate with at least three biological replicates. The ratio of
each mRNA relative to the 18S rRNA was calculated using the
2-ΔΔCT method.
RNA extraction from skin biopsy samples
Shave biopsies from non-lesional and lesional skin of
psoriatic patients as well as healthy control skin biopsies were
collected as described previously [46]. After removal of the
subcutaneous tissue, skin biopsies were incubated overnight at
4°C in Dispase solution (Roche Diagnostics). On the following
day, the epidermis was separated from the dermis and
samples mounted in 1ml of TRIzol Reagent (Life Technologies)
to which 400µl chloroform (Sigma) was added and vortexed
vigorously. Samples were centrifuged at 13000rpm for 10













minutes and the upper phase was loaded onto gDNA eliminator
spin columns of the RNeasy Plus Mini Kits (Qiagen).
Subsequent RNA extraction and quantification as well as cDNA
synthesis and QRT-PCR was performed as described above.
All tissue samples were taken with the patient’s written
informed consent and the approval of the University of Szeged
Ethical Committee. The study was conducted according to the
Declaration of Helsinki Principles.
SAGE-Seq
Buffy-coats of healthy individuals were obtained at three
different occasions, and subsequent monocyte-isolation,
dendritic cell differentiation and finally the RNA isolation was
performed in three different experiments, as described above.
SAGE-Seq [11] was performed using SOLiD SAGE kit (Life
Technologies) according to the manufacturer’s instructions.
Briefly, purified total RNA from three independent experiments,
representing three healthy A+ blood-donors, was pooled in
equimolar ratios and was bind to Dynabeads Oligo(dT) EcoP
magnetic beads in order to capture polyadenilated RNAs.
cDNA was synthesized on the magnetic beads by using
SuperScriptIII Reverse Transcriptase and E. coli DNA
polymerase. Next, NlaIII restriction was performed in order to
generate GTAC containing sticky end at the complementary
DNA strand. Barcode adaptor A was ligated, which contains an
EcoP15I restriction enzyme recognition site and a truncated
internal adaptor sequence. An EcoP15I digestion was carried
out to cleave the construct off from the magnetic beads.
EcoP15I restriction also resulted in 2 base-pair long
overhanging tag. Adaptor B was joined to the 5’ end of each
tag which contains the P1 primer binding site. Each library was
amplified in an emulsion PCR, sequencing beads deposited on
sequencing slide and sequenced on SOLiD V4 System (Life
Technologies).
It is important to emphasize, that due to the limited amount to
input RNA, we pooled RNA from three independent
experiments, subsequently, SAGE sequencing was performed
on one RNA pool per each of the three experimental groups.
Table 2. SybrGreen primer sets used in QRT-PCR experiments.
Gene Forward (5' -3') Reverse (5' -3') product length (bp)
CXCL10 TTGTTCCACGTGTTGAGATCATTG GCAGCCCTCTGTGTGGTCCATC 188
CCL1 CTTCACCAGGCTCATCAAAGCTG TCTGGAGAAGGGTACCTGCAT 150
gp130 TCCCTGCCTGTGACTTTCAAGGG AGGTCCTTTGGAAGGTGGAGCTTG 140
IL-10RA GTCAGTCCCAGCCCAAGGGTAG AGCTCTGTCCCATGAGCGTCTG 154
IL-17A ATCACAATCCCACGAAATCCAG CTTTGCCTCCCCAGATCACAGAG 207
IL-17RA GCATCACCACAGGCGGTGG AGGGATGGGGCTTGGGCAGGT 100
TNFAIP3 GCTGAAAACGAACGGTGACGG AGAGACTCCAGTTGCCAGCGG 159
TGF-β TGTCACCGGAGTTGTGCGG GGCCGGTAGTGAACCCGTTGATG 131
CycB2 TGGCTCCAAAGGGTCCTTCTCCC CTGCAGAGCTGAGGGTTCTCCCA 139
CycD1 TCAAGTGTGACCCGGACTGCCT ACGTCGGTGGGTGTGCAAGC 160
CASP8 AACAGCTTCAGAAGAAGGAGCAG AGGTTCAAGTGACCAACTCAAGGGG 101
FADD CTGGGGAAGAAGACCTGTGTGCAG GCTCTGTCAGGTTGCGGGGG 144
doi: 10.1371/journal.pone.0073435.t002
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Data availability
Short-read archive of the three sequenced libraries was
deposited in NCBI’s Short Read Archive at http://
www.nvbi.nlm.nih.gov/sra/ under accession SRA076165.
Bioinformatic analysis of SAGE-Seq
For mapping of SAGE-Seq tags to the human transcriptome
we created virtual libraries containing all the possible 18 bases
length sequences of ENSEMBL human transcript data set
(version: GRCh37.58) located next to an NlaIII restriction site.
Virtual tag libraries and the pre-processed and quality filtered
SAGE-Seq libraries were uploaded into an in house developed
data warehouse [47]. Mappings were performed by the
relational database engine of the data warehouse in a way that
only perfect matches over the entire 22 bp length of the 18 bp
tag plus the 4 bp NlaIII recognition site were allowed. During
the mapping process the system tracked the so-called multiple
mapping events where tags detected in the experiments could
be assigned to more than one transcript. Statistical comparison
of SAGE-Seq data from different samples was performed using
the Bayesian method described by Lash et al. [12]. Briefly, a
key-by-key comparison of two key-count distributions was
performed by generating a probability that the frequency of any
key in the distribution differs by more than a given fold factor
from the other distribution. The algorithm performs the
statistical analysis by taking into account the potential
difference in the total size of the tag libraries compared. In our
analysis we used a 2-fold factor difference of transcript
expression level as the subject of the Bayesian statistical
evaluation. According to the suggestion of Chen et al. [48] the c
parameter value of simplified beta distribution function, that
corresponds to parameters a and b of the original function, was
set to 2. The algorithm returns a probability value (p) for each
tag describing the chance that the detected count numbers
represent a fold difference of the tag concentration between the
investigated samples greater than or equal to 2. The change of
a tag expression was accepted as significant if p was above
0.95.
Gene enrichment studies
For uncovering the biological processes represented in the
massive output of the high-throughput SAGE-Seq experiments
we executed gene enrichment studies using gene ontology
(GO) [49] and Kegg [50] pathway databases as the source of
gene annotation information. The extraction of the
overrepresented annotation categories, and the underlying
statistical calculations were performed by DAVID, a high-
throughput data-mining software tool. For the enrichment
calculations we used the DAVID default population background
containing all human genes with at least one annotation in the
analyzed categories. To check the significance of gene
enrichment, DAVID applies a modified Fisher’s exact test [51].
The enrichment p-values produced by the Fisher’s exact test
were corrected by Benjamini multiple testing method to control
family-wide false discovery rate. Gene annotation categories
were accepted to be significantly overrepresented when the
associated p value was less than 0.05 after Benjamini
correction.
Measurements for secreted cytokine levels
Harvested cell culture supernatants were centrifuged and the
concentrations of secreted TNF-α and CCL1 were measured
by Quantikine Human Immunoassay Kits (R&D Systems)
following the manufacturer’s instructions. Serial dilutions of the
respective recombinant human proteins were used to generate
standard curves. The optical density of each well was
determined using a microplate reader (FLUOstar Optima, BMG
Labtech) set to 450nm with a wavelength correction set to
540nm.
Detection of apoptosis using fluorescent microscopy
Immature dendritic cells were grown on glass coverslips and
after appropriate treatments cells were fixed with 4% (w/v)
paraformaldehyde for 4 min at room temperature and washed
with phosphate-buffered saline (PBS). Cells were incubated
with PBS containing 1% (v/v) FBS (Gibco) for 1 hour at room
temperature. After washing with Annexin binding buffer (ABB;
10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2), samples
were incubated with ABB in the presence of 1:40 diluted Alexa
488-conjugated Annexin V (Invitrogen; Life Technologies) for
30 min and washed twice with ABB. Samples were mounted in
Citifluor mounting media (Citifluor) to prevent quenching. The
images were captured with an Olympus Fluoview FV1000
confocal laser scanning microscope (Olympus Life Science
Europa) and quantified with ImageJ. The extent of apoptosis
was calculated from fluorescence intensity as follows:
fluorescence intensity of induced or tolerant iDCs /
fluorescence intensity of naïve cells and is shown in %.
Data representation and statistical analysis
Data show median (horizontal black bar), interquartile range
(box) and minimum and maximum values. The significance of
differences between sets of data was determined by Student’s
paired t-test using SPSS Statistics for Windows. A p value of
less than 0.05 was considered significant.
Supporting Information
Figure S1.  The expression pattern of proinflammatory
mediators and receptors in induced and tolerant iDCs at
48h. The relative gene expression of pro-inflammatory
mediators CXCL8 (A), CCL1(B) and IL-6 (C) remained
significantly upregulated at 48h post first PGN treatment. The
ratio of each mRNA relative to the 18S rRNA was calculated
using the 2-ΔΔCT method. Data are representative of 3 or more
independent experiments and are presented as interquartile
range (box) with median (horizontal black bar) and minimum
and maximum values. The significance of differences between
sets of data was determined by Student’s paired t-test using
SPSS Statistics; *p<0.05.
(TIF)
Figure S2.  The expression pattern of TNF-α and TNF-α
regulated genes in induced and tolerant iDCs at 48h. The
relative gene expression of TNF-α (A) and TNFAIP6 (C)
remains upregulated, the expression of TNFAIP8 (D) remains
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significantly downregulated and there is no change in the
expression level of TNFAIP3 (B) at 48h post first PGN
treatment. The ratio of each mRNA relative to the 18S rRNA
was calculated using the 2-ΔΔCT method. Data are
representative of 3 or more independent experiments and are
presented as interquartile range (box) with median (horizontal
black bar) and minimum and maximum values. The
significance of differences between sets of data was
determined by Student’s paired t-test using SPSS Statistics;
*p<0.05.
(TIF)
Table S1.  Significantly enriched biological process gene
ontology annotations among transcripts that showed changes
in expression upon PGN stimulation and restimulation of iDCs.
(XLS)
Table S2.  Significantly enriched Kegg pathways among
transcripts that showed changes in expression upon PGN
stimulation and restimulation of iDCs.
(XLS)
Acknowledgements
We thank Marianna Nagymihály and Balázs Horváth for the
help with SAGE-Seq experiments, dr Roberta Fajka-Boja and
dr Ferhan Ayaydin for the help with annexin V labeling, dr Attila
Balogh for helpful comments on the use of infliximab and dr
Nóra Belső for the help with collecting skin biopsy samples.
Author Contributions
Conceived and designed the experiments: ZH IN. Performed
the experiments: KF ZH ASz IN. Analyzed the data: FK ZH ASz
VT LK EK IN. Wrote the manuscript: FK ZH IN.
References
1. Kondo T, Kawai T, Akira S (2012) Dissecting negative regulation of
Toll-like receptor signaling. Trends Immunol 33: 449-458. doi:10.1016/
j.it.2012.05.002. PubMed: 22721918.
2. Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry:
linking microbial infections to chronic inflammation and cancer. Cell
124: 823-835. doi:10.1016/j.cell.2006.02.016. PubMed: 16497591.
3. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D et al. (2002)
SOCS1/JAB is a negative regulator of LPS-induced macrophage
activation. Immunity 17: 583-591. doi:10.1016/S1074-7613(02)00446-6.
PubMed: 12433365.
4. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A et al. (2002)
SOCS-1 participates in negative regulation of LPS responses. Immunity
17: 677-687. doi:10.1016/S1074-7613(02)00449-1. PubMed:
12433373.
5. Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA et al.
(2011) The adaptor protein FADD protects epidermal keratinocytes
from necroptosis in vivo and prevents skin inflammation. Immunity 35:
572-582. doi:10.1016/j.immuni.2011.08.014. PubMed: 22000287.
6. West MA, Heagy W (2002) Endotoxin tolerance: A review. Crit Care
Med 30: S64-S73. doi:10.1097/00003246-200201001-00009. PubMed:
1189140611782563.
7. Cavaillon JM, Adib-Conquy M (2006) Bench-to-bedside review:
endotoxin tolerance as a model of leukocyte reprogramming in sepsis.
Crit Care 10: 233. doi:10.1186/cc5055. PubMed: 17044947.
8. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov
V et al. (2003) Induction of in vitro reprogramming by Toll-like receptor
(TLR)2 and TLR4 agonists in murine macrophages: effects of TLR
"homotolerance" versus "heterotolerance" on NF-kappaB signaling
pathway components. J Immunol 170: 508-519. PubMed: 12496438.
9. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H et al. (2003)
Molecular mechanisms of macrophage activation and deactivation by
lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100:
171-194. doi:10.1016/j.pharmthera.2003.08.003. PubMed: 14609719.
10. Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control
of inflammation by TLR-induced chromatin modifications. Nature 447:
972-978. PubMed: 17538624.
11. Siebert S, Robinson MD, Tintori SC, Goetz F, Helm RR et al. (2011)
Differential gene expression in the siphonophore Nanomia bijuga
(Cnidaria) assessed with multiple next-generation sequencing
workflows. PLOS ONE 6: e22953. doi:10.1371/journal.pone.0022953.
PubMed: 21829563.
12. Lash AE, Tolstoshev CM, Wagner L, Schuler GD, Strausberg RL et al.
(2000) SAGEmap: a public gene expression resource. Genome Res
10: 1051-1060.
13. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H et al. (1999) KEGG:
Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27:
29-34. doi:10.1093/nar/27.20.e29. PubMed: 9847135.
14. Foti M, Granucci F, Pelizzola M, Beretta O, Ricciardi-Castagnoli P
(2006) Dendritic cells in pathogen recognition and induction of immune
responses: a functional genomics approach. J Leukoc Biol 79: 913-916.
doi:10.1189/jlb.1005547. PubMed: 16641136.
15. Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-
presentation by dendritic cells. Nat Rev Immunol 12: 557-569. doi:
10.1038/nri3254. PubMed: 22790179.
16. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA et al.
(2001) Subsets of human dendritic cell precursors express different toll-
like receptors and respond to different microbial antigens. J Exp Med
194: 863-869. doi:10.1084/jem.194.6.863. PubMed: 11561001.
17. Bamias G, Evangelou K, Vergou T, Tsimaratou K, Kaltsa G et al.
(2011) Upregulation and nuclear localization of TNF-like cytokine 1A
(TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp
Dermatol 20: 725-731. doi:10.1111/j.1600-0625.2011.01304.x.
PubMed: 21672030.
18. Sun H, Gong S, Carmody RJ, Hilliard A, Li L et al. (2008) TIPE2, a
negative regulator of innate and adaptive immunity that maintains
immune homeostasis. Cell 133: 415-426. doi:10.1016/j.cell.
2008.03.026. PubMed: 18455983.
19. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q et al. (2011) The unique
expression profile of human TIPE2 suggests new functions beyond its
role in immune regulation. Mol Immunol 48: 1209-1215. doi:10.1016/
j.molimm.2011.03.001. PubMed: 21459448.
20. Zhang G, Hao C, Lou Y, Xi W, Wang X et al. (2010) Tissue-specific
expression of TIPE2 provides insights into its function. Mol Immunol 47:
2435-2442. doi:10.1016/j.molimm.2010.06.016. PubMed: 20663561.
21. Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat
Rev Immunol 8: 327-336. doi:10.1038/nri2303. PubMed: 18421305.
22. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM
receptors are pleiotropic inhibitors of the innate immune response. Cell
131: 1124-1136. doi:10.1016/j.cell.2007.10.034. PubMed: 18083102.
23. Szász A, Strifler G, Vörös A, Váczi B, Tubak V et al. (2013) The
expression of TAM receptors and their ligand Gas6 is downregulated in
psoriasis. J Dermatol Sci 71: 215-216. doi:10.1016/j.jdermsci.
2013.04.018. PubMed: 23684948.
24. Nigg EA (1995) Cyclin-dependent protein kinases: key regulators of the
eukaryotic cell cycle. Bioessays 17: 471-480. doi:10.1002/bies.
950170603. PubMed: 7575488.
25. Van Parijs L, Abbas AK (1998) Homeostasis and self-tolerance in the
immune system: turning lymphocytes off. Science 280: 243-248. doi:
10.1126/science.280.5361.243. PubMed: 9535647.
26. Wahl SM, Wen J, Moutsopoulos N (2006) TGF-beta: a mobile purveyor
of immune privilege. Immunol Rev 213: 213-227. doi:10.1111/j.
1600-065X.2006.00437.x. PubMed: 16972906.
27. Chen M, Wang J (2010) Programmed cell death of dendritic cells in
immune regulation. Immunol Rev 236: 11-27. doi:10.1111/j.1600-065X.
2010.00916.x. PubMed: 20636805.
Transcriptome Profiling of Dendritic Cells
PLOS ONE | www.plosone.org 12 September 2013 | Volume 8 | Issue 9 | e73435
28. Hueber AJ, McInnes IB (2007) Immune regulation in psoriasis and
psoriatic arthritis--recent developments. Immunol Lett 114: 59-65. doi:
10.1016/j.imlet.2007.08.009. PubMed: 17928070.
29. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and
chemokine network in psoriasis. Clin Dermatol 25: 568-573. doi:
10.1016/j.clindermatol.2007.08.011. PubMed: 18021894.
30. Szász A, Strifler G, Vörös A, Váczi B, Tubak V et al.. (2013) The
expression of TAM receptors and their ligand Gas6 is downregulated in
psoriasis. J Dermatol Sci, 71: 215–6. PubMed: 23684948.
31. Schulz BS, Michel G, Wagner S, Süss R, Beetz A et al. (1993)
Increased expression of epidermal IL-8 receptor in psoriasis. Down-
regulation by FK-506 in vitro. J Immunol 151: 4399-4406. PubMed:
7691948.
32. Lee EG, Boone DL, Chai S, Libby SL, Chien M et al. (2000) Failure to
regulate TNF-induced NF-kappaB and cell death responses in A20-
deficient mice. Science 289: 2350-2354. doi:10.1126/science.
289.5488.2350. PubMed: 11009421.
33. Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R et al. (2011)
Expression of A20 by dendritic cells preserves immune homeostasis
and prevents colitis and spondyloarthritis. Nat Immunol 12: 1184-1193.
doi:10.1038/ni.2135. PubMed: 22019834.
34. Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P et al. (2010)
The ubiquitin modifying enzyme A20 restricts B cell survival and
prevents autoimmunity. Immunity 33: 181-191. doi:10.1016/j.immuni.
2010.07.017. PubMed: 20705491.
35. Kool M, van Loo G, Waelput W, De Prijck S, Muskens F et al. (2011)
The ubiquitin-editing protein A20 prevents dendritic cell activation,
recognition of apoptotic cells, and systemic autoimmunity. Immunity 35:
82-96. doi:10.1016/j.immuni.2011.05.013. PubMed: 21723156.
36. Jiang X, Tian H, Fan Y, Chen J, Song Y et al. (2012) Expression of
tumor necrosis factor alpha-induced protein 3 mRNA in peripheral
blood mononuclear cells negatively correlates with disease severity in
psoriasis vulgaris. Clin Vaccine Immunol 19: 1938-1942. doi:10.1128/
CVI.00500-12. PubMed: 23054742.
37. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE et al. (2009) Genome-
wide scan reveals association of psoriasis with IL-23 and NF-kappaB
pathways. Nat Genet 41: 199-204. doi:10.1038/ng.311. PubMed:
19169254.
38. Woodward MJ, de Boer J, Heidorn S, Hubank M, Kioussis D et al.
(2010) Tnfaip8 is an essential gene for the regulation of glucocorticoid-
mediated apoptosis of thymocytes. Cell Death Differ 17: 316-323. doi:
10.1038/cdd.2009.125. PubMed: 19730441.
39. Williams SC (2012) New biologic drugs get under the skin of psoriasis.
Nat Med 18: 638. doi:10.1038/nm0512-638. PubMed: 22561807.
40. Sockolov ME, Alikhan A, Zargari O (2009) Non-psoriatic dermatologic
uses of monoclonal antibody therapy. J Dermatol Treat 20: 319-327.
doi:10.3109/09546630902936778. PubMed: 19954387.
41. Musacchio E, Valvason C, Botsios C, Ostuni F, Furlan A et al. (2009)
The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits
interleukin 1beta (IL-1beta) and IL-6 gene expression in human
osteoblastic cells. J Rheumatol 36: 1575-1579. doi:10.3899/jrheum.
081321. PubMed: 19567627.
42. Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza
RC et al. (2005) CCL1-CCR8 interactions: an axis mediating the
recruitment of T cells and Langerhans-type dendritic cells to sites of
atopic skin inflammation. J Immunol 174: 5082-5091. PubMed:
15814739.
43. N’Diaye M, Le Ferrec E, Kronenberg F, Dieplinger H, Le Vee M et al.
(2009) TNFalpha- and NF-kappaB-dependent induction of the
chemokine CCL1 in human macrophages exposed to the atherogenic
lipoprotein(a). Life Sci 84: 451-457. doi:10.1016/j.lfs.2009.01.012.
PubMed: 19302817.
44. Kim HO, Cho SI, Chung BY, Ahn HK, Park CW et al. (2012) Expression
of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin Exp
Dermatol 37: 521-526. doi:10.1111/j.1365-2230.2011.04295.x.
PubMed: 22680616.
45. Nagy I, Filkor K, Németh T, Hamari Z, Vágvölgyi C et al. (2011) In vitro
interactions of Candida parapsilosis wild type and lipase deficient
mutants with human monocyte derived dendritic cells. BMC Microbiol
11: 122. doi:10.1186/1471-2180-11-122. PubMed: 21619700.
46. Belsõ N, Széll M, Pivarcsi A, Kis K, Kormos B et al. (2008) Differential
expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. J
Invest Dermatol 128: 634-642. PubMed: 17882269.
47. Hegedus Z, Zakrzewska A, Agoston VC, Ordas A, Rácz P et al. (2009)
Deep sequencing of the zebrafish transcriptome response to
mycobacterium infection. Mol Immunol 46: 2918-2930. doi:10.1016/
j.molimm.2009.07.002. PubMed: 19631987.
48. Chen H, Centola M, Altschul SF, Metzger H (1998) Characterization of
gene expression in resting and activated mast cells. J Exp Med 188:
1657-1668. doi:10.1084/jem.188.9.1657. PubMed: 9802978.
49. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H et al. (2000)
Gene ontology: tool for the unification of biology. Gene Ontology
Consortium Nat Genet 25: 25-29.
50. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) KEGG for
integration and interpretation of large-scale molecular data sets.
Nucleic Acids Res 40: D109-D114. doi:10.1093/nar/gkr988. PubMed:
22080510.
51. Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics
enrichment tools: paths toward the comprehensive functional analysis
of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/
gkp505. PubMed: 19033363.
Transcriptome Profiling of Dendritic Cells
PLOS ONE | www.plosone.org 13 September 2013 | Volume 8 | Issue 9 | e73435
